Latest Strategy Changes News

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.

BHP Group Limited reported a robust half-year to December 2025, with copper overtaking iron ore as the top earnings contributor and a detailed technical assessment released for its promising Vicuña copper-gold project.

Altitude Minerals has successfully drilled the T55 Target at its Byrock Project in New South Wales, confirming a copper-gold porphyry system consistent with the Macquarie Arc extension. This milestone supports advancing their earn-in agreement and sets the stage for further exploration.

SEEK Limited reported robust H1 FY2026 results, powered by AI-driven product innovation and pricing, delivering strong revenue and profit growth alongside a record interim dividend. However, a significant impairment on its Zhaopin investment weighed on reported earnings.

SEEK Limited posted strong half-year revenue growth and record dividends, but a hefty impairment charge on its Chinese associate Zhaopin led to a significant net loss. The company’s strategic platform unification and Sidekicker reacquisition underpin operational momentum despite macroeconomic headwinds.

The Central Tanami Project joint venture between MGX Resources and Tanami Gold NL reports a 2.8 million ounce gold resource, progressing towards production with key infrastructure upgrades and exploration drilling underway.

Black Canyon Limited (ASX, BCA) has unveiled promising exploration results and positive scoping studies for its manganese and iron projects in Western Australia, positioning itself as a key emerging developer in the sector.

Alligator Energy is progressing its Samphire Uranium Project in South Australia into trial production, supported by strong project economics and promising exploration potential. The company targets first uranium production by 2030/31 while derisking operations through a Field Recovery Trial.

Sims Limited reported a 3.7% rise in half-year sales revenue to A$3.78 billion, propelled by strong non-ferrous prices and robust growth in its Lifecycle Services division. Underlying EBIT soared 65.9%, reflecting strategic acquisitions and operational efficiencies despite challenging ferrous markets.

Sims Limited reported a robust fiscal 2026 half-year underlying profit, boosted by strong performances in its Lifecycle Services and North American metal operations. Despite statutory losses from derivative impacts, the company declared a healthy interim dividend and outlined strategic investments for future growth.

Tetratherix Limited reveals promising interim results for TetraDerm, its scar prevention product, showing minimal scarring in patients after skin lesion surgeries. The product’s unique approach could reshape wound closure in a $US2.1 billion market.

Baby Bunting has reported record half-year sales and margin growth for 1H FY26, underpinned by its Store of the Future refurbishments and strategic expansions. The company maintains its full-year profit guidance while unveiling a new exclusive partnership with premium brand Stokke.